Needham & Company Downgrades Genocea Biosciences (GNCA) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Genocea Biosciences (GNCA) Misses Q4 EPS by 11c
February 16, 2017 7:36 AM ESTGenocea Biosciences (NASDAQ: GNCA) reported Q4 EPS of ($0.56), $0.11 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $0, versus $0 reported last year.
Cash, cash equivalents and investments as of December 31, 2016 were $63.4 million compared to $75.5 million as of September 30, 2016.
For earnings... More
